Julie Laterreur

Julie Laterreur is an accomplished expert in drug metabolism and pharmacokinetics with extensive experience in the pharmaceutical industry. As the Principal Investigator DMPK at Ventus Therapeutics since June 2024, Julie leads critical DMPK initiatives. Previously, Julie served as Senior Director and Head of DMPK at Genesis Therapeutics, where responsibilities included solving complex DMPK issues and overseeing multidisciplinary project core teams. Julie’s tenure at Vertex Pharmaceuticals spanned over a decade, including roles as Research Fellow I and Senior Research Scientist, where Julie made significant contributions to drug discovery and development, received the Vertex Platinum VOCAP award for innovative DMPK achievements, and played a crucial role in regulatory filings. Early experience includes positions at ViroChem Pharma and Merck Frosst Canada, with foundational training in chemistry and biochemistry earned through a Master’s degree from Concordia University and a Bachelor of Science from Université de Sherbrooke.